HC Wainwright & Co. Maintains Buy on Compass Pathways, Lowers Price Target to $65

Benzinga · 2d ago
HC Wainwright & Co. analyst Patrick R. Trucchio maintains Compass Pathways (NASDAQ:CMPS) with a Buy and lowers the price target from $70 to $65.